| ID | 64371 |
| JaLCDOI | |
| フルテキストURL | |
| 著者 |
Amano, Katsuhiko
Department of Oral and Maxillofacial Reconstructive Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Sugauchi, Akinari
The first department of Oral and Maxillofacial Surgery, Osaka University Graduate School of Dentistry
Yamada, Chiaki
Department of Oral and Maxillofacial Reconstructive Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kogo, Mikihiko
The first department of Oral and Maxillofacial Surgery, Osaka University Graduate School of Dentistry
Iida, Seiji
Department of Oral and Maxillofacial Reconstructive Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kaken ID
publons
researchmap
|
| 抄録 | Medication-related osteonecrosis of the jaw (MRONJ) is a side effect in patients taking bone-modifying agents (BMAs), which are highly beneficial for treating osteoporosis and cancer. Bisphosphonates are prescribed to treat secondary osteoporosis in patients with rheumatoid arthritis (RA). We recently encountered two unusual cases of intraoral ONJ in RA patients who had not been treated with a BMA and did not have features of methotrexate- associated lymphoproliferative disorder. Their ONJ stage II bone exposures were treated by conservative therapy, providing good prognoses. These cases indicate that ONJ can occur in RA patients not treated with bisphosphonates. Several risk factors are discussed.
|
| キーワード | osteonecrosis of the jaw
rheumatoid arthritis
risk factor
bisphosphonate
|
| Amo Type | Case Report
|
| 出版物タイトル |
Acta Medica Okayama
|
| 発行日 | 2023-02
|
| 巻 | 77巻
|
| 号 | 1号
|
| 出版者 | Okayama University Medical School
|
| 開始ページ | 111
|
| 終了ページ | 116
|
| ISSN | 0386-300X
|
| NCID | AA00508441
|
| 資料タイプ |
学術雑誌論文
|
| 言語 |
英語
|
| 著作権者 | Copyright Ⓒ 2023 by Okayama University Medical School
|
| 論文のバージョン | publisher
|
| 査読 |
有り
|
| PubMed ID | |
| Web of Science KeyUT |
